NDC 83301-0004-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0004
- Requested NDC
- 83301-0004-01
- Package NDCs from labels
- 83301-0004-1, 83301-0004-2, 83301-0004-3, 83301-0004-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | 2025-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0004-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 10 | |
| 83301-0004-2 | Gabapentin | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 10 | |
| 83301-0004-3 | Gabapentin | 1000 in 1 BOTTLE, PLASTIC | CAPSULE | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0004 | GABAPENTIN CAPSULE [MULLAN PHARMACEUTICAL INC.] | 9 | Current NDC, 3 package rows | 20250411_74474aa4-4859-42d2-92d8-f23f18b34e04.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0004-1 | EA - Each | 83301-0004 | 68147702-10bf-45ab-8778-32f3f1b00f3e | 1 | 2024-10-04 |
| 83301-0004-2 | EA - Each | 83301-0004 | 8f01f50a-eb39-445e-a88a-4f1145bc24d1 | 1 | 2025-07-08 |
| 83301-0004-3 | EA - Each | 83301-0004 | 36e8797a-1182-42cb-aee7-d954f67ee1ce | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Revlon Colorstay Liquid Makeup for Oily to Combination Skin | ZINC OXIDE, TITANIUM DIOXIDE MAKE-UP | Revlon Consumer Products Corp | 410d1cb2-6c92-1ca3-e054-00144ff8d46c | 2024-12-31 | Warnings | 15FIX9V2JP |
| REVLON PHOTOREADY INSTA-FIX MAKEUP | TITANIUM DIOXIDE, ZINC OXIDE | Revlon Consumer Products Corp | 442f2a06-47c0-2522-e054-00144ff88e88 | 2024-12-31 | Warnings | 15FIX9V2JP |
| Revlon Youth FX | ZINC OXIDE, TITANIUM DIOXIDE MAKE-UP | Revlon Consumer Products Corp | 442dec1e-032c-28de-e054-00144ff8d46c | 2024-12-31 | Warnings | 15FIX9V2JP |
| Almay Smart Shade Skintone Matching Makeup Medium | TITANIUM DIOXIDE ZINC OXIDE | Almay, Inc. | 2a971e38-af63-e069-e063-6294a90a8f77 | 2024-12-31 | Warnings | 15FIX9V2JP |
| REVLON AGE DEFYING FIRMING LIFTING MAKEUP SPF 15 | OCTINOXATE, TITANIUM DIOXIDE MAKE-UP | Revlon Consumer Products Corp | d9209277-469d-48f4-bf64-f39a70c19596 | 2024-12-31 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | afa28969-91ca-83fd-e053-2a95a90a656b | 2024-12-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | afa28969-91c8-83fd-e053-2a95a90a656b | 2024-12-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Almay Smart Shade Skintone Matching Makeup Light | TITANIUM DIOXIDE ZINC OXIDE | Almay, Inc. | 2a987b85-efdb-eb95-e063-6394a90aef81 | 2024-12-31 | Warnings | 15FIX9V2JP |
| ALMAY SMART SHADE ANTI-AGING SKINTONE MATCHING MAKEUP SPF 20 Light | TITANIUM DIOXIDE, ZINC OXIDE | Almay, Inc. | 2a984dd9-7293-77f0-e063-6294a90a8f1e | 2024-12-31 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | ADVANCED RX OF TENNESSEE, LLC | af73fbd8-9731-e6bf-e053-2995a90af65d | 2024-12-31 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | afc80b8b-da39-6fb9-e053-2a95a90a2d8e | 2024-12-31 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | b062f12c-a745-76d4-e053-2a95a90a3a1a | 2024-12-31 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | b33c18ea-554d-3cfb-e053-2a95a90a2dd1 | 2024-12-31 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | b37b1dcc-c7e9-8845-e053-2995a90a089e | 2024-12-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx Pharmacy of Tennessee, LLC | c898711b-9a65-1816-e053-2995a90a855e | 2024-12-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | d294f6aa-ed82-90a2-e053-2995a90a2896 | 2024-12-31 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx Pharmacy of Tennessee, LLC | ec1c621b-db2a-1567-e053-2995a90a8695 | 2024-12-31 | Warnings, Adverse reactions | ANDA075477 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx Pharmacy of Tennessee, LLC | c89a68b6-6dc0-4624-e053-2a95a90a687e | 2024-12-31 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx Pharmacy of Tennessee, LLC | bc08e35d-ef5d-1dcd-e053-2a95a90ab5de | 2024-12-31 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advanced Rx Pharmacy of Tennessee, LLC | c859e666-d510-426b-e053-2995a90a9a3c | 2024-12-31 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.